To most investors, hedge funds are seen as slow, outdated financial vehicles of the past. While there are more than 8000 funds in operation at the moment, we look at the leaders of this group, around 450 funds.

On the clinical data front, Sanofi SA (ADR) (NYSE:SNY) delivered positive news to investors on Friday with its JAK2 inhibitor SAR302503.

There's little denying that Roche Holding Ltd. (ADR) (OTCBB:RHHBY)'s cancer wonder drug Avastin has been a godsend to cancer patients and investors alike.

Micron Technology, Inc.(NASDAQ:MU) shares climbed 0.52% to $9.58. The company, on April 24, announced that its Hybrid Memory Cube was named the Memory Product of the Year by a panel of industry experts.

Banco Santander, S.A. (ADR)(NYSE:SAN)went down 2.73% and closed at $7.13 on a traded volume of 5.27million shares. ... Sanofi SA (ADR)(NYSE:SNY)decreased 2.65% and closed at $53.29 on a traded volume of 2.42 million shares.So far this year, the ...

As of March 31, 2013, cash, cash equivalents and investments totaled $61.6 million. Is CYTK a Strong Buy After The Recent Gain? Let's Find out Here Sanofi SA (ADR)(NYSE:SNY) shares fell 2.39% to $53.04. The company's vaccines division, Sanofi Pasteur, ...

Sanofi SA (ADR) (NYSE:SNY) recently won an FDA approval for its drug Kynamro, which treats the same disease, meaning that Aegerion will have to compete with a company that has many times more resources in order to successfully market its drug.

These stocks are GlaxoSmithKline plc (ADR) (NYSE:GSK), Merck & Co., Inc. (NYSE:MRK), Sanofi SA (ADR) (NYSE:SNY), Novartis AG (ADR) (NYSE:NVS), and Pfizer Inc. (NYSE:PFE).

French drug maker Sanofi SA (SNY, SAN.FR) Thursday said it expects a return to growth later in the year as the effects of lost patent protection on certain drugs eases and new products come through the company's pipeline.

Another stock of the similar sector Sanofi SA (ADR) (NYSE:SNY) has the market capitalization of $144.87 billion. The company's EPS was 2.44 while its 2.65 billion shares were outstanding.